Dapagliflozin vs Tildrakizumab

## Dapagliflozin vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between **Dapagliflozin** and **Tildrakizumab**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

## Pharmacokinetics

**Half-life**: Dapagliflozin — 12.9 hours; Tildrakizumab — N/A.

## Chemical Properties

**Molecular Formula**: Dapagliflozin — C21H25ClO6; Tildrakizumab — N/A.

**Molecular Weight**: Dapagliflozin — 408.8730 g/mol; Tildrakizumab — N/A.

**Type**: Dapagliflozin — Small molecule; Tildrakizumab — Antibody.